help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, D. S.
Right arrow Articles by Ridgway, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, D. S.
Right arrow Articles by Ridgway, E. C.

Endocrinology, Vol 112, 2050-2053, Copyright © 1983 by Endocrine Society


ARTICLES

Changes in tissue concentrations of thyrotropin, free thyrotropin beta, and alpha-subunits after thyroxine administration: comparison of mouse hypothyroid pituitary and thyrotropic tumors

DS Ross, MF Downing, WW Chin, JD Kieffer and EC Ridgway

We have previously demonstrated divergent changes in pituitary free TSH beta and alpha-subunit concentrations in hypothyroid mice during prolongation of experimental hypothyroidism and after T4 administration. This report compares the simultaneous responses of pituitary and thyrotropic tumor TSH, TSH beta, and alpha-subunit to 12 days of T4 administration in four groups of hypothyroid LAF1 mice bearing thyrotropic tumors. Half of each group received daily injections of T4 (10 micrograms/100 g BW, ip) for 12 days; the other half of each group received saline. Plasma concentrations of TSH, free TSH beta, and free alpha-subunit were suppressed by T4 administration to 0.1-1.5%, 2.0-3.9%, and 4.1-25% of control concentrations, respectively. Pituitary TSH and free TSH beta concentrations fell significantly with treatment to 24-43% and 10-28% of control concentrations, respectively. In contrast, pituitary alpha-subunit concentrations did not fall (they were 106-203% of control values), and a rise in the pituitary alpha-subunit concentration was statistically significant in one group (P less than 0.02). Thyrotropic tumor TSH and free TSH beta concentrations fell significantly with treatment to 9-31% and 8-35% of control concentrations, respectively. Tumor alpha-subunit concentrations did not fall (they were 87-195% of control values), and a 2-fold rise was statistically significant in one group (P less than 0.05). Both pituitary and tumor alpha-subunit to TSH beta molar ratios increased significantly with T4 administration in all groups. We conclude that (1) pituitary and thyrotropic tumor TSH beta concentrations fall after 12 days of T4 administration while alpha- subunit concentrations are unchanged or actually rise; (2) this divergent response is qualitatively similar in hypothyroid mouse pituitary and thyrotropic tumors; and (3) these data suggest differences between the regulation of intracellular TSH beta and alpha- subunit.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
D. F. Gordon, E. A. Tucker, K. Tundwal, H. Hall, W. M. Wood, and E. C. Ridgway
MED220/Thyroid Receptor-Associated Protein 220 Functions as a Transcriptional Coactivator with Pit-1 and GATA-2 on the Thyrotropin-{beta} Promoter in Thyrotropes
Mol. Endocrinol., May 1, 2006; 20(5): 1073 - 1089.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Christoffolete, R. Ribeiro, P. Singru, C. Fekete, W. S. da Silva, D. F. Gordon, S. A. Huang, A. Crescenzi, J. W. Harney, E. C. Ridgway, et al.
Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-Mediated Pituitary Thyrotropin Feedback Mechanism
Endocrinology, April 1, 2006; 147(4): 1735 - 1743.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. F. Gordon, W. W. Woodmansee, S. R. Lewis, R. A. James, W. M. Wood, and E. C. Ridgway
Cloning of the Mouse Somatostatin Receptor Subtype 5 Gene: Promoter Structure and Function
Endocrinology, December 1, 1999; 140(12): 5598 - 5608.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. M. Staton and P. J. Leedman
Posttranscriptional Regulation of Thyrotropin {beta}-Subunit Messenger Ribonucleic Acid by Thyroid Hormone in Murine Thyrotrope Tumor Cells: A Conserved Mechanism across Species
Endocrinology, March 1, 1998; 139(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. D. Sarapura, H. L. Strouth, D. F. Gordon, W. M. Wood, and E. C. Ridgway
Msx1 Is Present in Thyrotropic Cells and Binds to a Consensus Site on the Glycoprotein Hormone {alpha}-Subunit Promoter
Mol. Endocrinol., November 1, 1997; 11(12): 1782 - 1794.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. F. Gordon, S. R. Lewis, B. R. Haugen, R. A. James, M. T. McDermott, W. M. Wood, and E. C. Ridgway
Pit-1 and GATA-2 Interact and Functionally Cooperate to Activate the Thyrotropin beta -Subunit Promoter
J. Biol. Chem., September 26, 1997; 272(39): 24339 - 24347.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society